APA (7th ed.) Citation

P, N., A, C., D, W., SK, B., & K, D. (2025). A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysis. BMC nephrology, 26(1), 453. https://doi.org/10.1186/s12882-025-04367-x

Chicago Style (17th ed.) Citation

P, Navarro-Gonzales, Chavan A, Wang D, Burke SK, and Dykstra K. "A Randomized Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Patients with Anemia Associated with Chronic Kidney Disease Receiving Hemodialysis." BMC Nephrology 26, no. 1 (2025): 453. https://doi.org/10.1186/s12882-025-04367-x.

MLA (9th ed.) Citation

P, Navarro-Gonzales, et al. "A Randomized Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Patients with Anemia Associated with Chronic Kidney Disease Receiving Hemodialysis." BMC Nephrology, vol. 26, no. 1, 2025, p. 453, https://doi.org/10.1186/s12882-025-04367-x.